Hager Alicia J.

Chief Legal Officer at NKTX; SVP & General Counsel at OncoMed Pharmaceuticals Inc

Sold, on record
$587k
Dollars the filings state
Form 4 sales
19
Latest Jan 15, 2025
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale OncoMed Pharmaceuticals IncPlan not stated
    Oct 10, 2018 2018

    Sold 1,156 shares at $2.02 ($2k)

    Hager Alicia J., SVP & General Counsel

    Sold 2.2% of holdings ($107k position)51,754 shares left0.3x usual sizeFiling

  2. 2 Form 4 sale NKTXPlan not stated
    Jan 17, 2023 +1560 days

    Sold 1,103 shares at $5.49 ($6k)

    Hager Alicia J., Chief Legal Officer

    Sold 1.9% of holdings ($320k position)57,197 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale NKTXNo plan
    Jun 20, 2023 +154 days

    Sold 701 shares at $4.85 ($3k)

    Hager Alicia J., Chief Legal Officer

    No 10b5-1 planSold 1.2% of holdings ($277k position)56,496 shares leftFiling

  4. 4 Form 4 sale NKTXNo plan
    Jan 16, 2024 +210 days

    Sold 4,554 shares at $8.74 ($40k)

    Hager Alicia J., Chief Legal Officer

    No 10b5-1 planSold 4% of holdings ($983k position)107,942 shares leftFiling

  5. 5 Form 4 sale NKTXNo plan
    Jun 18, 2024 +154 days

    Sold 727 shares at $5.60 ($4k)

    Hager Alicia J., Chief Legal Officer

    No 10b5-1 planSold 0.7% of holdings ($604k position)107,215 shares left0.7x usual sizeFiling

  6. 6 Form 144 notice NKTXNotice
    Jul 16, 2024 +28 days

    Filed to sell 3,396 shares ($24k)

    Hager Alicia J., Officer

    10b5-1 plan3.7x usual sizeFiling

  7. 7 Form 4 sale NKTXUnusual
    Jul 16, 2024 same day

    Sold 3,396 shares at $8.00 ($27k)

    Hager Alicia J., Chief Legal Officer

    10b5-1 planSold 3.2% of holdings ($858k position)103,819 shares left3.7x usual sizeFollows a Form 144Filing

  8. 8 Form 4 sale NKTXUnusual
    Jan 15, 2025 +183 days

    Sold 9,584 shares at $2.20 ($21k)

    Hager Alicia J., Chief Legal Officer

    No 10b5-1 planSold 6.1% of holdings ($344k position)146,735 shares left8.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (20)

Form 144 notices and Form 4 sales by Hager Alicia J.
Source
Jan 15, 2025Jan 17, 2025NKTXChief Legal OfficerForm 4 sale9,584$21k6.1%UnusualSEC
Jul 16, 2024Jul 18, 2024NKTXChief Legal OfficerForm 4 sale3,396$27k3.2%UnusualSEC
Jul 16, 2024Jul 16, 2024NKTXOfficerForm 144 notice3,396$24kNoticeSEC
Jun 18, 2024Jun 20, 2024NKTXChief Legal OfficerForm 4 sale727$4k0.7%No planSEC
Jan 16, 2024Jan 18, 2024NKTXChief Legal OfficerForm 4 sale4,554$40k4.0%No planSEC
Jun 20, 2023Jun 22, 2023NKTXChief Legal OfficerForm 4 sale701$3k1.2%No planSEC
Jan 17, 2023Jan 18, 2023NKTXChief Legal OfficerForm 4 sale1,103$6k1.9%Plan not statedSEC
Oct 10, 2018Oct 11, 2018OncoMed Pharmaceuticals IncSVP & General CounselForm 4 sale1,156$2k2.2%Plan not statedSEC
Oct 9, 2018Oct 10, 2018OncoMed Pharmaceuticals IncSVP & General CounselForm 4 sale1,686$4k3.1%Plan not statedSEC
Apr 24, 2018Apr 26, 2018OncoMed Pharmaceuticals IncSVP & General CounselForm 4 sale4,051$11k6.9%Plan not statedSEC
Oct 10, 2017Oct 12, 2017OncoMed Pharmaceuticals IncSVP & General CounselForm 4 sale1,248$5k2.1%Plan not statedSEC
Apr 4, 2017Apr 5, 2017OncoMed Pharmaceuticals IncSVP & General CounselForm 4 sale4,316$39k16.7%Plan not statedSEC
Mar 15, 2017Mar 17, 2017OncoMed Pharmaceuticals IncSVP & General CounselForm 4 sale6,652$67k20.4%UnusualSEC
Jan 7, 2016Jan 8, 2016OncoMed Pharmaceuticals IncVP & General CounselForm 4 sale1,623$36k10.8%Plan not statedSEC
Nov 27, 2015Dec 1, 2015OncoMed Pharmaceuticals IncVP & General CounselForm 4 sale1,800$42k10.7%Plan not statedSEC
Oct 27, 2015Oct 29, 2015OncoMed Pharmaceuticals IncVP & General CounselForm 4 sale5,400$113k26.5%UnusualSEC
Jul 28, 2015Jul 29, 2015OncoMed Pharmaceuticals IncVP & General CounselForm 4 sale1,800$38k10.7%Plan not statedSEC
Jun 29, 2015Jun 30, 2015OncoMed Pharmaceuticals IncVP & General CounselForm 4 sale1,800$41k10.7%Plan not statedSEC
May 27, 2015May 28, 2015OncoMed Pharmaceuticals IncVP & General CounselForm 4 sale1,800$42k10.7%Plan not statedSEC
Apr 27, 2015Apr 29, 2015OncoMed Pharmaceuticals IncVP & General CounselForm 4 sale1,800$46k10.7%Plan not statedSEC